References
Rospond RM, Quandt CM, Clark GM, Bussey HI (1989) Evaluation of factors associated with stability of anticoagulation therapy. Pharmacotherapy 9:207–213
Veeger NJGM, Piersma-Wichers M, Hillege HL, Cruns HJGM, van der Meer J (2006) Early detection of patients with a poor response to vitamin K antagonists: the clinical impact of individual time within target range in patients with heart disease. J Thromb Haemost 4:1625–1627
Thoma BN, Barron L, Anderson MM, Walker MB, Bussey HI (2007) The feasibility and potential value of automated online anticoagulation monitoring of warfarin-treated patients. In: Abstract 336 Am Coll Clin Pharm meeting, Denver, Colorado, 15 Oct 2007
White HD, Gruber M, Feyzi J, Kaatz S et al (2007) Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med 167:239–245
Chimowitz MI, Lynn MJ, Howlett-Smith H et al (2005) Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 352:1305–1316
Ryan F, Byrne S, O’Shea S (2008) Randomized controlled trial of supervised patient self-testing of warfarin therapy using an Internet based expert system. Blood (ASH Annual Meeting Abstracts) 2008: 112 (Abstract 879)
Harper PL, Pollock D (2008) Anticoagulation self-management using near patient testing and decision support software provided via an Internet Website improved anticoagulation control in patients on long-term warfarin. Blood (ASH Annual Meeting Abstracts) 2008: 112 (Abstract #1278)
Bussey HI, Walker MB, Bussey-Smith KL, Frei CR. Interim analysis of triple intervention to improve International Normalized Ratio (INR) control in warfarin treated patients. In: International Society of Thrombosis and Haemostasis meeting 2009 (abstract PP-MO-469)
Acknowledgments
I am very grateful for the generous assistance of Mary Amato, Pharm.D. and Diane Wirth, A.P.R.N. for very valuable contributions to this effort.
Disclosures
Minor stock holder in Inverness Medical, the parent company of HemoSense, maker of the INRatio point of care device. Co-owner of a provisional patent for several vitamin K antagonist products. Research support from Roche Diagnostics, Inc (makers of the CoaguChek point of care device). Recipient of the GSK Distinguished Scholar in Thrombosis Award from the Chest Foundation of the American College of Chest Physicians to develop a better method of oral anticoagulation management. Consultant to Genesis Advanced Technologies, Inc. on the development and design of ClotFree, an online anticoagulation management system. President and Senior Editor of ClotCare.org.
Author information
Authors and Affiliations
Corresponding author
Additional information
Note: Any reference to acceptable billing codes, Medicare policies, reimbursement amounts, etc., the reader should not rely on the content contained herein; rather the reader is encouraged to contact their regional Medicare payor, review the current “Medicare Manual”, and/or visit the following websites: http://www.cms.hhs.gov/, http://www.cms.hhs.gov/MLNGenInfo/.
Rights and permissions
About this article
Cite this article
Bussey, H.I. The financial viability of an anticoagulation clinic: a discussion from the anticoagulation forum meeting, May, 2009. J Thromb Thrombolysis 29, 227–232 (2010). https://doi.org/10.1007/s11239-009-0417-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-009-0417-0